Loading...
CORM-3 induces DNA damage through Ru(II) binding to DNA
Lyon, R.F. Southam, H.M. Trevitt, C.R. Liao, C. Poole, R.K. Williamson, M.P.
Lyon, R.F.
Southam, H.M.
Trevitt, C.R.
Liao, C.
Poole, R.K.
Williamson, M.P.
Publication Date
2022-07-04
End of Embargo
Supervisor
Keywords
Rights
(c) 2022 The Authors. This is an Open Access article distributed under the Creative Commons CC-BY license (https://creativecommons.org/licenses/by/4.0/)
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2022-06-21
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
When the 'CO-releasing molecule-3', CORM-3 (Ru(CO)3Cl(glycinate)), is dissolved in water it forms a range of ruthenium complexes. These are taken up by cells and bind to intracellular ligands, notably thiols such as cysteine and glutathione, where the Ru(II) reaches high intracellular concentrations. Here, we show that the Ru(II) ion also binds to DNA, at exposed guanosine N7 positions. It therefore has a similar cellular target to the anticancer drug cisplatin, but not identical, because Ru(II) shows no evidence of forming intramolecular crossbridges in the DNA. The reaction is slow, and with excess Ru, intermolecular DNA crossbridges are formed. The addition of CORM-3 to human colorectal cancer cells leads to strand breaks in the DNA, as assessed by the alkaline comet assay. DNA damage is inhibited by growth media containing amino acids, which bind to extracellular Ru and prevent its entry into cells. We conclude that the cytotoxicity of Ru(II) is different from that of platinum, making it a promising development target for cancer therapeutics.
Version
Published version
Citation
Lyon RF, Southam HM, Trevitt CR et al (2022) CORM-3 induces DNA damage through Ru(II) binding to DNA. Biochemical Journal. 479(13): 1429-1439.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article